Safety and efficacy of etanercept and adalimumab in children aged 2 to 4 years with juvenile idiopathic arthritis.
about
Safety and efficacy of etanercept and adalimumab in children aged 2 to 4 years with juvenile idiopathic arthritis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Safety and efficacy of etanerc ...... juvenile idiopathic arthritis.
@en
Safety and efficacy of etanerc ...... juvenile idiopathic arthritis.
@nl
type
label
Safety and efficacy of etanerc ...... juvenile idiopathic arthritis.
@en
Safety and efficacy of etanerc ...... juvenile idiopathic arthritis.
@nl
prefLabel
Safety and efficacy of etanerc ...... juvenile idiopathic arthritis.
@en
Safety and efficacy of etanerc ...... juvenile idiopathic arthritis.
@nl
P2860
P1476
Safety and efficacy of etanerc ...... juvenile idiopathic arthritis.
@en
P2093
D Windschall
P2860
P304
P356
10.1007/S10067-016-3439-Y
P577
2016-10-05T00:00:00Z